Glenmark has wind knocked out of NDA for respiratory drug by FDA 0 24.06.2019 18:20 Fiercepharma.com An early development effort from India’s Glenmark has stumbled on manufacturing issues, prompting the FDA to seek fixes ahead of an approval. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
